US pharma major Bristol Myers Squibb—in collaboration with Johnson & Johnson—has announced the decision to stop the Phase III ...

TandemAI has announced that it has secured a $22 million Series A extension to further develop its drug discovery platform, ...

Merck & Co has struck a $9.2 billion deal to acquire biotechnology company Cidara Therapeutics in a move that bolsters the US ...

US medtech firm Terumo Blood and Cell Technologies has appointed Liza Loidolt as general manager of its cell and gene therapy ...

Ireland-based Avadel Pharmaceuticals today announced that it has received an unsolicited proposal from Denmark’s Lundbeck to ...

The US Food and Drug Administration approved USA-based Kura Oncology and Japan’s Kyowa Kirin’s ziftomenib (trade name ...

German generics and consumer healthcare major STADA Arzneimittel has appointed Craig Shaw as its general manager in the UK.

Gate Bioscience has raised $65 million in an oversubscribed series B to advance its first molecular gate candidates, a novel ...

Chinese biotech Biokin Pharmaceutical (SHA: 688506) has postponed its planned Hong Kong share listing, citing “prevailing ...

UK-based life sciences venture capital firm Medicxi today announced the closing of Medicxi V, a 500 million-euros ($579.5 ...

The pharma trade group the Association of the British Pharmaceutical Industry (ABPI) and the UK government have agreed to a ...

Neurvati Neurosciences, the neuroscience development platform of Blackstone Life Sciences, has announced the appointment of ...